TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LIVN

LivaNova PLC

Healthcare · Medical Devices

78.00$ +0.3% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns LivaNova PLC (LIVN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 112.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 112.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 99.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 55Mio.

Largest Shareholders

Institutions

Institutions LIVN
Name Stake (%) Shares Change (%) Date
BlackRock Inc 12.96 7,138,908 -2.5 03/31/2026
PRIMECAP Management Company 7.57 4,168,377 -0.9 06/30/2026
FMR Inc 4.84 2,666,674 +5,711.9 03/31/2026
AQR Capital Management LLC 4.53 2,494,372 +15.7 03/31/2026
Artisan Partners Limited Partnership 4.04 2,224,763 +4.8 06/30/2026
State Street Corp 3.76 2,072,679 +3.0 03/31/2026
American Century Companies Inc 3.66 2,013,774 +12.2 06/30/2026
Dimensional Fund Advisors, Inc. 3.35 1,845,285 +1.0 06/30/2026

Funds

Funds LIVN
Name Stake (%) Shares Change (%) Date
iShares Core S&P Mid-Cap ETF 3.49 1,922,727 +0.0 08/31/2026
Vanguard Capital Opportunity Inv 3.45 1,902,700 -0.5 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings LIVN
Person Role Shares Value As of Type
Story Brooke Director 7,488 584,064 $ Sep 4, 2026 direct
Tezel Ahmet Chief Innovation Officer 6,090 475,020 $ Aug 11, 2026 direct
Bianchi Francesco Director 4,434 345,852 $ Sep 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 10, 2026 Bianchi Francesco Director Sell 3,500 78.01 273,032
Sep 4, 2026 Story Brooke Director Sell 2,300 81.42 187,270
Aug 31, 2026 Bianchi Francesco Director Sell 1,650 79.72 131,538
Aug 11, 2026 Tezel Ahmet Chief Innovation Officer Sell 2,675 77.74 207,942
Aug 11, 2026 Tezel Ahmet Chief Innovation Officer Other 1,428 77.86 111,184
Aug 11, 2026 Tezel Ahmet Chief Innovation Officer Other 8,589 77.86 668,740
Aug 11, 2026 Tezel Ahmet Chief Innovation Officer Other 12,692 52.68 668,615

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?